Clinical Trials Browser

Recruiting × Recurrence × relmacabtagene autoleucel × Clear all

NCT05806580 2024-10-23

Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma

Phase 4 Recruiting

Recurrence, Lymphoma, B-Cell

NCT06479356 2024-08-21

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

Phase 2 Recruiting

Lymphoma, Non-Hodgkin, Recurrence